Novel technology to improve pharmaceutical productivity.
A review of the literature published from late 1997 to the end of 1998 reveals a shift in paradigm of the discovery process and hence the productivity of pharmaceutical companies. Key factors are combined use in high-throughput screening systems. The increasing quantity of data, places information technology at the core of driving efficiency in R&D. Increasing importance is also given to organizational structures and teamwork within the pharmaceutical industry. This review outlines the progress that has been made and discusses both the future direction of key elements and limitations to increasing R&D productivity within the pharmaceutical industry.
Krebs
R
R
Boehringer Ingelheim GmbH, Binger Strasse, Postfach 200, D-55216 Ingelheim, Germany. krebs@ing.boehringer-ingelheim.com